Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR3 | P49019 | 8/20 | 0.50 |
| ▸ | RARB | P10826 | 4/20 | 0.46 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | PLA2G4B | P0C869 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10095114 | 0.85 | HCAR3 (0.55) | HCAR3HCAR2MAPT | |
| SCHEMBL9960384 | 0.80 | HCAR3 (0.52) | HCAR3RARBHCAR2TP53TSHR | |
| SCHEMBL9960380 | 0.78 | HCAR3 (0.47) | HCAR3HCAR2MAPT | |
| SCHEMBL26673673 | 0.78 | NR1I2 (0.40) | MAPT | |
| SCHEMBL20989341 | 0.77 | TSHR (0.43) | TSHRMAPT | |
| SCHEMBL18595311 | 0.77 | RAB9A (0.43) | — | |
| SCHEMBL19103030 | 0.74 | ESR1 (0.42) | TSHRMAPT | |
| SCHEMBL10954997 | 0.74 | TP53 (0.54) | RARBTP53TSHRPLA2G4BMAPT | |
| SCHEMBL10955282 | 0.74 | TP53 (0.54) | RARBTP53TSHRPLA2G4BMAPT | |
| SCHEMBL10957990 | 0.74 | TP53 (0.54) | RARBTP53TSHRPLA2G4BMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9999687-B2 | Fluorescent imaging agents | VISEN MEDICAL, INC. (US) | 2018-06-19 | — | — | US | disclosed |
| US-20170119908-A1 | Fluorescent Imaging Agents | VISEN MEDICAL, INC. | 2017-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170119908-A1 | Fluorescent Imaging Agents | DNPEP, FURIN, MME | HCAR3 913/4885RARB 3859/4885HCAR2 1922/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.